Saban Capital Group Chairman & CEO, Haim Saban, joins 'Influencers with Andy Serwer' to discuss consolidation and M&A in the media industry.
Saban Capital Group Chairman & CEO, Haim Saban, joins 'Influencers with Andy Serwer' to discuss consolidation and M&A in the media industry.
The supermarket chain, which also owns Argos, is looking to reduce its office space in Manchester, London and Milton Keynes.
The "Sea and Coastal Water Transport in Ghana 2020" report has been added to ResearchAndMarkets.com's offering.
(Bloomberg) -- Prime Minister Boris Johnson’s government is being accused of dropping its pledge to end austerity after cutting a further 4 billion pounds ($5.8 billion) a year for departments in the budget.The reductions in day-to-day spending plans unveiled on Wednesday by Chancellor of the Exchequer Rishi Sunak set the stage for a challenging review of resources for government ministries later this year. It adds to savings of over 12 billion pounds announced just four months ago and suggests a squeeze for everything except health, defense and education.Johnson swept to power in 2019 on a pledge to “level up” poorer regions and end years of cuts introduced by then finance minister George Osborne to tackle what was at the time a record budget deficit following the financial crisis. But his plans have been made more difficult by the even bigger levels of borrowing to get the country through the coronavirus pandemic.“It’s not going to feel like the end of austerity if you run a prison or bits of local government,” Torsten Bell, chief executive officer of the Resolution Foundation research group, said in briefing Thursday. “On public services, it’s going to feel like George Osborne is still around.”Sunak combined stimulus this year with plans for spending cuts and billions of pounds of tax increases on companies and individuals in the biggest revenue-raising budget since 1993. The overall tax burden is on course to reach the highest since the late 1960s, according to the Office for Budget Responsibility.In an analysis of the budget, the Institute for Fiscal Studies said so-called unprotected areas will see their budgets fall by around 1% in real terms in 2022-23, adding to the plight of departments such as the Home Office and the Ministry of Justice that bore the brunt of Osborne’s austerity drive.“It’s going to be something that feels a bit like austerity for at least some public services if we are going to keep to these public spending plans,” said Deputy Director Carl Emmerson. “It will be cuts coming on top of that very tight period of spending restraint for those areas.”Some questioned whether the current spending plans can be delivered, given the pressure to increase resources for the National Health Service and education in light of the pandemic. That could mean that even larger tax rises are required in the future to put the debt burden on a downward path.In broadcast interviews on Thursday, Sunak defended his budget, saying the Conservative government has increased day-to-day and capital spending by almost 70 billion pounds since being elected.“That’s a huge increase, delivering on our promises for more nurses, more police officers, more hospitals, leveling up across the country,” Sunak told BBC Radio. “Over the course of this parliament you will see public spending grow at what are historically high levels as we deliver on all of those commitments.”For more articles like this, please visit us at bloomberg.comSubscribe now to stay ahead with the most trusted business news source.©2021 Bloomberg L.P.
Aggressor Adventures Consumer Travel Index indicates fascinating results about consumers' 2021 travel plans & the health benefits of being on water
So, what about Prince Andrew?
The France 2023 organising committee is aiming to make the Sept. 8 to Oct. 28 tournament the most accessible Rugby World Cup of all time after the match schedule was announced last week. Fans will also be able to buy tickets through one of the 24 official travel agents who have 200,000 tickets reserved for the tournament.
Chancellor Rishi Sunak said he enjoys pizza and burgers but they should be consumed in ‘moderation’.
Germany has approved giving the AstraZeneca Covid-19 vaccine to people aged 65 and over. Health minister Jens Spahn said the country's independent vaccine committee had made the decision, hailing it "good news for older people who are waiting for a vaccination”. The vaccine made by British-Swedish company and developed by Oxford University is one of three authorised for use in the 27-nation European Union.
Suspending the income threshold for paying the highest rate of tax means more than one in 10 workers will be paying the highest rate of tax for the first time in history.
Dublin, March 04, 2021 (GLOBE NEWSWIRE) -- The "Global Proteomics market (2020-2025) by Instrumentation Technology, Reagents, Services & Software, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The Global Proteomics Market is estimated to be USD 20.3 Bn in 2020 and is expected to reach USD 35.6 Bn by 2025, growing at a CAGR of 12%.The transformation of the biopharmaceutical industry's focus from genomics to system biology has led to an increase in the demand for proteomics. Also, certain drug manufacturers have started with their proteomic divisions boosting the growth of this market. The market is highly characterized by R&D investments and an increasing number of collaborations between enterprises.Factors such as increasing demand for personalized medicine with a need to curb down the costs on healthcare by promoting effective drugs and the rise in the R&D for the former have promoted the growth of the proteomics market.However, the constraining factor for market growth is strict regulatory norms and the instruments' high cost. Lack of skilled professionals in the proteomics industry impedes the growth of the market. The opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities to the market.Market Dynamics Drivers Increase in Popularity of Personalized MedicinesAn Upsurge in R&D ExpenditureTechnological Advancements Associated with Proteomics Components Restraints High Costs Associated with Proteomics ComponentsThe dearth of Skilled ProfessionalsHuge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities Opportunities Lucrative Opportunities Associated with Biomarker IdentificationDevelopments in Mass Spectrometry-Based ProteomicsAvailability of Government and Private FundingTechnological Advancements Challenges Regulatory Barriers Trends Development in Mass Spectrometry-Based Proteomics Segments Covered By Instrumentation Technology, the Protein Fractionation segment is expected to grow at the highest rate during the forecast period. This growth is due to the benefits of Protein Fractionation of effectively separating thousands of proteins in a complex structure and high resolution. The need for the analysis of complex structures is increasing in proteomics research.By Reagent, the Protein Fractionation Reagents segment is expected to witness a faster growth rate during the forecast period. The growth can be attributed to the increasing need for protein separation from complex mixtures, thereby moving towards effective analysis.By Services & Software, the Core Proteomics Services accounted for the largest share of the market. These services are the basis of proteomics and are highly adopted at every stage of proteome analysis.By Application, the Clinical Diagnostics Segment holds the largest share of the proteomics market. This can be attributed to the increased adoption of the relevance of investigating and understanding patterns of protein expression for disease diagnostics and drug development.By Geography, North America is estimated to lead the market. The factors attributing to the growth of this market are advanced technology with increased adoption of proteomic components for the development of personalized therapeutics. Besides, there has been extensive research and development on next-gen therapeutics. Further, the region boasts of hundreds of modified therapeutic proteins for clinical use, which has further contributed to this growth. The Asia Pacific is also expected to show the highest growth during the forecast period due to the increasing investments by governments and industries, growing R&D activities, and raising awareness of personalized therapeutics.The Global Proteomics market is further segmented based on Instrumentation Technology, Reagents, Services & Software, Application, and Geography.Company Profiles Some of the companies covered in this report are Agilent Technologies Inc., Danaher Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc., HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric (GE), and Waters Corporation.Competitive Quadrant The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market.Tortoise: Companies that are slow in growth, having a long legacy, and stable or negative in performance.Why buy this report? The report offers a comprehensive evaluation of the Global Proteomics Market.The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.The report includes in-depth market analysis using Porter's 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.The report also contains a competitive analysis using Positioning Quadrants, a Proprietary competitive positioning tool. Report Highlights: A complete analysis of the market including parent industryImportant market dynamics and trendsMarket segmentationHistorical, current, and projected size of the market based on value and volumeMarket shares and strategies of key playersRecommendations to companies for strengthening their foothold in the market Key Topics Covered: 1 Report Description1.1 Study Objectives 1.2 Market Definition1.3 Currency1.4 Years Considered1.5 Language1.6 Key Shareholders2 Research Methodology2.1 Research Process2.2 Data Collection and Validation2.2.1 Secondary Research2.2.2 Primary Research2.3 Market Size Estimation2.4 Assumptions of the Study2.5 Limitations of the Study3 Executive Summary4 Market Overview4.1 Introduction 4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.2.4 Challenges4.3 Trends5 Market Analysis5.1 Porter's Five Forces Analysis5.2 Impact of COVID-195.3 Ansoff Matrix Analysis6 Global Proteomics Market, By Instrumentation Technology6.1 Introduction6.2 Spectroscopy6.2.1 Mass Spectroscopy 6.2.2 Nmr Spectroscopy 6.2.3 Cd Spectroscopy 6.3 Chromatography 6.3.1 HPLC6.3.2 Ion Chromatography6.3.3 Affinity Chromatography 6.3.4 Supercritical Fluid Chromatography 6.4 Electrophoresis 6.4.1 Gel Electrophoresis6.4.2 Capillary Electrophoresis6.5 Protein Microarrays6.5.1 Biochips220.127.116.11 Lab-on-chips (Microfluidics)18.104.22.168 Protein Chips6.5.2 Microarray Instruments22.214.171.124 Integrated Systems126.96.36.199 Microarray Scanners188.8.131.52 Arrayers6.6 X-Ray Crystallography6.7 Surface Plasmon Resonance 6.8 Protein Fractionation7 Global Proteomics Market, By Reagents7.1 Introduction7.2 Microarray7.3 Spectrometry7.4 X-ray crystallography7.5 Chromatography7.6 Electrophoresis7.7 Immunoassay7.8 Protein fractionation reagents8 Global Proteomics Market, By Services & Software8.1 Introduction8.2 Core Proteomics Services8.2.1 Protein Identification Services8.2.2 Protein Characterization Services8.2.3 Quantitative Proteomics Services8.2.4 Protein Purification Services8.2.5 Protein Separation Services8.2.6 Protein Sequencing Services8.2.7 Custom Assay Services8.3 Bioinformatics Software & Services8.3.1 Bioinformatics Services8.3.2 Bioinformatics Tools8.3.3 Bioinformatics Databases9 Global Proteomics Market, By Application9.1 Introduction9.2 Drug Discovery9.3 Clinical Diagnostics9.4 Others10 Global Proteomics Market, By Geography10.1 Introduction10.2 North America10.2.1 US10.2.2 Canada10.2.3 Mexico10.3 South America10.3.1 Brazil10.3.2 Argentina10.1 Europe10.1.1 UK10.1.2 France10.1.3 Germany10.1.4 Italy10.1.5 Spain10.1.6 Rest of Europe10.2 Asia-Pacific10.2.1 China10.2.2 Japan10.2.3 India10.2.4 Indonesia10.2.5 Malaysia10.2.6 South Korea10.2.7 Australia10.2.8 Russia10.2.9 Rest of APAC10.3 Rest of the World10.3.1 Qatar10.3.2 Saudi Arabia10.3.3 South Africa10.3.4 United Arab Emirates10.3.5 Latin America11 Competitive Landscape11.1 IGR Competitive Quadrant11.2 Market Share Analysis11.3 Competitive Scenario11.3.1 Mergers & Acquisitions11.3.2 Agreements, Collaborations, & Partnerships11.3.3 New Product Launches & Enhancements11.3.4 Investments & Fundings12 Company Profiles12.1 Agilent Technologies, Inc.12.2 Danaher Corporation (Beckman Coulter, Inc.)12.3 Li-Cor Inc.12.4 PerkinElmer Inc.12.5 Thermo Fisher Scientific, Inc.12.6 Horiba Ltd.12.7 Bio-Rad Laboratories, Inc.12.8 Bruker Corporation (Beckman Coulter, Inc.)12.9 Ge Healthcare (General Electric)12.10 Waters Corporation (Beckman Coulter, Inc.) 12.11 Roche Diagnostics13 Appendix13.1 QuestionnaireFor more information about this report visit https://www.researchandmarkets.com/r/vdccyb CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager email@example.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
The "Medical Aesthetics Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 To 2029" report has been added to ResearchAndMarkets.com's offering.
DraftKings (NASDAQ: DKNG) and Chewy (NYSE: CHWY) are two incredible growth stocks that are just getting started. DraftKings continues to thrive as more states legalize sports wagering. Meanwhile, Chewy is riding the wave of increased spending as a result from the shift from in-person to online shopping -- a trend that was accelerated during the pandemic.
Their 30-year friendship was one of the closest in politics and together they took on Westminster. But now Nicola Sturgeon and Alex Salmond have turned on each other and it is all out war. What does this mean for Scotland and the union?
Stock futures traded lower Thursday morning after another session of equity declines. Technology stocks came under more selling pressure as traders turned their focus to stocks poised to benefit from an impending economic reopening.
The Government is also contributing £100m towards fitness and weight-loss courses
The murder conviction of a former altar boy who carried out the vigilante killing of a man he wrongly believed was a paedophile has been upheld by judges. Christopher Hunnisett bludgeoned Peter Bick with a hammer and strangled him with a shoelace, just months after being released from prison over another killing. Court of Appeal judges were asked to review the conviction and consider if Hunnisett was suffering from paranoid schizophrenia at the time of the attack.
Mariah Carey's brother follows sister in suing over memoirMorgan Carey says passages in The Meaning of Mariah Carey that characterise him as violent are ‘false and defamatory’ Mariah Carey performing in 2019. Photograph: Kamran Jebreili/AP
Scientists have become concerned about several variants, including one first identified in the Brazilian city of Manaus.
"In Veneto l'indice Rt è a 1,12. Si torna a ballare, in senso negativo". Lo dice il presidente della regione Luca Zaia illustrando il bollettino di oggi, 4 marzo, sull'emergenza e i contagi di Coronavirus. In Veneto nelle ultime 24 ore ci sono stati 1.487 contagi e 20 morti. L'incidenza è al 3,62%. "Ho sentito il ministro Speranza stamattina, di certo ci sono regioni più in sofferenza di noi e a livello nazionale l'Italia si sta colorando sempre di più di arancione, arancione scuro e rosso", sottolinea Zaia nel consueto punto stampa. "Mi sembra di capire che, in diverse misure e modalità, l'azione sulla scuola è in corso. E' innegabile che davanti a questa infezione la prima preoccupazione va ai ragazzi e alle loro famiglie", evidenzia il governatore veneto. "Noi abbiamo un indice Rt di 1,12, anche se non abbiamo ancora tassi di ospedalizzazione importanti", dice ancora Zaia, spiegando che "abbiamo un tasso di occupazione del 12% delle terapie intensive e del 17% nei ricoveri in area non critica, ma siamo preoccupati dall'andamento e da quello che sta succedendo nelle altre regioni". "Con questo Rt -prosegue-, con questi dati e la circolazione del virus penso sia verosimile purtroppo di tornare a ballare un po'. L'aereo può avere turbolenze in volo, ma i cittadini possono darci una mano". Per quanto riguarda la scuola, Zaia precisa che "non si è deciso ancora nulla sulla chiusura delle scuole. In questa fase stiamo facendo una analisi seria della situazione epidemiologica nelle scuole secondo logiche comunali, sono preoccupato e seguirò a vista la scuola".
‘Screeching U-turn’ on Tory low-tax policy will leave UK with ‘highest sustained burden in history’